Literature DB >> 1064142

Insulin secretion in the Zollinger-Ellison syndrome.

J F Rehfeld, K B Lauritsen, F Stadil.   

Abstract

The insulin response to oral glucose ingestion was measured in six patients with the Zollinger-Ellison (ZE) syndrome, five patients with partial gastrectomy (antrectomy for duodenal ulcer) and six matched normal subjects. The blood glucose curves were similar in ZE-patients and gastrectomized controls and significantly above the glucose concentrations in normal controls. The insulin response was three-doubled in ZE-patients, whereas gastrectomized controls only doubled their response in comparison with the normal subjects. Treatment of a hepatic gastrinoma by streptozotocin infusion into the hepatic artery in a patient with diabetes mellitus and hyperinsulinism almost normalized his glucose tolerance and insulin secretion. The results demonstrate that the ZE-syndrome is associated with increased insulin release. We suggest that the hyperinsulinism partly is a consequence of previous gastric surgery and partly due to the insulinogenic effect of gastrin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1064142

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  4 in total

1.  Two distinct types of islet abnormalities associated with endocrine pancreatic tumours.

Authors:  L I Larsson
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1977-11-25

2.  Increased glucose disposal after jejuno-ileostomy.

Authors:  J F Rehfeld; K B Lauritsen; J J Holst
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

3.  Disturbed islet-cell function related to endogenous gastrin release. Studies on insulin secretion and glucose tolerance in pernicious anemia.

Authors:  J F Rehfeld
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

Review 4.  Premises for Cholecystokinin and Gastrin Peptides in Diabetes Therapy.

Authors:  Jens F Rehfeld
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2019-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.